Attorney General Pam Bondi Accused Of Dropping Foreign Bribery Investigation Into Big Pharma Former Client
By Danielle
Attorney General Pam Bondi faces accusations of making changes to Justice Department policy that may have benefited pharmaceutical giant Pfizer.
Before serving in her current role, Bondi provided outside legal counsel for Pfizer.
For the past several years, Pfizer has been under investigation for possible foreign bribery related to its activities in China and Mexico.
However, reports claim the company’s filings no longer mentioned the probe after Bondi became the nation’s top prosecutor.
click below for full story
Reuters stated in January this year:
Disclosures by President Donald Trump’s U.S. Attorney General nominee Pam Bondi and her former lobbying firm offer a peek into her finances, and at how Ballard Partners’ fortunes have grown as Trump’s political revival gained steam.
Bondi reported earning $1.06 million from the Tallahassee-founded firm, where she was a partner and represented the Florida Sheriff’s Association and Major County Sheriffs of America.
She also recorded $203, 738 in income working as a lawyer with Fort Lauderdale law firm Panza, Maurer & Maynard, according to her federal disclosure this month to the U.S. Office of Government Ethics. She listed pharma giant Pfizer as a past client.
Bondi disclosed she made $520,000 in consulting fees from the America First Policy Institute, a Trump-aligned think tank. The group’s website lists her as chair of its Center for Litigation and co-chair of its Center for Law and Justice.
The Senate voted to confirm Bondi as attorney general on February 4th in a 54-46 vote.
According to the Miami Herald, Pfizer’s most recent annual report, filed shortly after Bondi took office, did not refer to the DOJ investigations for possible foreign bribery.